Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1361-1380 of 1,857 trials

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00055913

This randomized phase I/II trial is to see if combining erlotinib with bevacizumab works better in treating patients who have recurrent or metastatic head and neck cancer. Erlotinib may stop the growth of tumor cells by blocking the enzymes needed for tumor cell growth. Monoclonal antibodies, such as bevacizumab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or deliver cancer-killing substances to them. Combining erlotinib with bevacizumab may kill more tumor cells.

Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+10 more

National Cancer Institute (NCI)58 participantsStarted Mar 2003

Chicago, Illinois, United States

TERMINATEDPhase 42.2 miles

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

NCT02680847

Safety and pharmacokinetics of an abuse-deterrent, extended-release formulation of oxycodone hydrochloride with a sequestered naltrexone core in children 7-17 with moderate-severe pain.

Moderate-severe Pain

Pfizer32 participantsStarted Jan 2016

Lancaster, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +13 more locations

Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Rheumatoid Arthritis Trials in Other Cities

Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection

Bevacizumab and Irinotecan or Temozolomide in Treating Patients With Recurrent or Refractory Glioblastoma Multiforme or Gliosarcoma

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor

Ganciclovir/Valganciclovir for Prevention of CMV Reactivation in Acute Injury of the Lung and Respiratory Failure

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Chocolate Balloon Angioplasty Registry

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Assessing Fitting Guides in Alcon Multifocal Contact Lenses

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Ultraviolet-A and Riboflavin Treatment for Infectious Keratitis

Safety, Tolerability, and Efficacy of GS-9876 in Participants With Active Rheumatoid Arthritis on Background Therapy With Methotrexate

Transfusion Requirements in Cardiac Surgery III

Preventing Hypoxemia With Manual Ventilation During Endotracheal Intubation (PreVent) Trial

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Pilot Study of X-82 in Patients With Wet AMD

Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods

Other Conditions in Chicago